The MS landscape has been comprehensively transformed over the last few years by progress in research and therapeutics. There are now 15 disease modifying therapies available in Australia for people with MS, and most of these are listed on the Pharmaceutical Benefits Scheme (PBS).MS is the most common acquired chronic neurological disease affecting